Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Hypocrellin A

😃Good
Catalog No. T5771Cas No. 77029-83-5

Hypocrellin A is a natural PKC inhibitor with light-induced antitumor, antifungal and antiviral activities and also exerts immunomodulatory effects on MHC-restricted antigen presentation.

Hypocrellin A

Hypocrellin A

😃Good
Purity: 99.95%
Catalog No. T5771Cas No. 77029-83-5
Hypocrellin A is a natural PKC inhibitor with light-induced antitumor, antifungal and antiviral activities and also exerts immunomodulatory effects on MHC-restricted antigen presentation.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$47In StockIn Stock
5 mg$122In StockIn Stock
10 mg$197In StockIn Stock
25 mg$397In StockIn Stock
50 mg$582In StockIn Stock
100 mg$829In StockIn Stock
500 mg$1,660-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.95%
Color:Red
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Hypocrellin A is a natural PKC inhibitor with light-induced antitumor, antifungal and antiviral activities and also exerts immunomodulatory effects on MHC-restricted antigen presentation.
Targets&IC50
PKC (from liver):0.07 μg/mL, HuCCT1 cells proliferation:10.01 μM (24h), RBE cells proliferation:4.612 μM (24h), IL-1β:0.103 μM, PKC (from soleus muscle):0.26 μg/mL
In vitro
Method: Three NSCLC cell lines H460, PC-9 and H19755 were treated with 0.01μM, 0.1μM, 0.5μM, 1μM, 5μM, 10μM, 50μM and 100μM HA for 48 hours, and IC50 was determined.
RESULTS The IC50 of Hypocrellin A against H1975, H460 and PC-9 were 0.2223μM, 0.2706μM and 0.6223μM respectively. [1]
METHODS: A549 cells were collected 12 or 24 h after 24 h treatment with 0.08 μmol/L Hypocrellin A-PDT and apoptosis was measured, aliquots of cell lysates were separated by SDS-PAGE, and lysates were analyzed by Western blotting PARP-1 levels.
RESULTS Hypocrellin A-mediated PDT significantly increased the apoptotic population of A549 cells, collectively showing an increase in the proportion of cells in the S phase and G2-M phase, and a decrease in the proportion of cells in the G0-G1 phase, and PARP cleavage in Hypocrellin A begins to occur 3 hours after PDT. [2]
METHODS: The isolated tissues of the liver and soleus skeletal muscle parts of the insulin target tissues of obese Zucker rats were treated with Hypocrellin A at concentrations of 0.01, 0.1, 1.0 and 10µg/ml respectively, and the activity of PKC enzyme was measured.
RESULTS The IC50 value of Hypocrellin A on liver PKC activity was 0.07µg/ml, and the IC50 value on soleus muscle PKC activity was 0.26µg/ml. [3]
In vivo
METHODS: H460 cells were transplanted into athymic female BALB/c nude mice. The mice in the experimental group were intraperitoneally injected with 2.5 mg/kg and 5 mg/kg Hypocrellin A every other day, and the tumor volume of the mice was observed.
RESULTS Hypocrellin A reduced NSCLC tumor weight and volume in a concentration-dependent manner. [1]
Cell Research
Cells were seeded in 96-well plates at a density of 1*10^4 cells in a final volume of 100 μl and maintained in DMEM medium at 37℃ ?.?After cells were treated with different concentrations of HA (5, 10, 20, 40, 80 μM), 20 μl 5 mg/ml MTT solution were added to each well and incubated for 4 h in the incubator.?Then 150 μl DMSO were added to each well to dissolve the pellet, keep it in the dark for 15 min, and dissolve the crystal completely.?Automatic microplate reader measured at 490 nm optical density (OD value).?The experiment was repeated three times.?For combination test, cells were treated with 20 μM Hypocrellin A?and different?concentrations of OA(25,50,100, 200 μM) .
Chemical Properties
Molecular Weight546.52
FormulaC30H26O10
Cas No.77029-83-5
SmilesCOc1cc(=O)c2c(O)c(OC)c3CC(C)(O)C(C(C)=O)c4c(OC)c(O)c5c6c(c(OC)cc5=O)c1c2c3c46
Relative Density.1.55 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 19.23 mg/mL (35.19 mM), Sonication and heating are recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.8298 mL9.1488 mL18.2976 mL91.4880 mL
5 mM0.3660 mL1.8298 mL3.6595 mL18.2976 mL
10 mM0.1830 mL0.9149 mL1.8298 mL9.1488 mL
20 mM0.0915 mL0.4574 mL0.9149 mL4.5744 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Hypocrellin A | purchase Hypocrellin A | Hypocrellin A cost | order Hypocrellin A | Hypocrellin A chemical structure | Hypocrellin A in vivo | Hypocrellin A in vitro | Hypocrellin A formula | Hypocrellin A molecular weight